Academic medical center CEOs are at the helm of some of the most complex and influential organizations in healthcare. They balance a three-part mission that includes delivering exceptional patient care, advancing cutting-edge research, and leading world-class education.
These executives guide institutions that serve as hubs for discovery and innovation, overseeing groundbreaking clinical trials, pioneering technologies and novel treatment models. Beyond the hospital walls, academic medical center CEOs often collaborate with government agencies, research partners and community organizations to expand access to care and improve public health.
Becker’s Healthcare developed this list based on nominations and editorial research.
President and CEO Dr. Debra F. Sukin was named to this prestigious list. Her summary is below:
Dr. Sukin leads one of the nation’s largest pediatric and women’s health systems, setting and executing a strategy centered on clinical excellence, innovation and equitable access across four hospital campuses and a statewide network of specialty and primary care sites. She oversees day-to-day operations, resource allocation, workforce development, and compliance and quality standards. Her early accomplishments as CEO include advancing a landmark collaboration with Houston-based The University of Texas MD Anderson Cancer Center to create a world-leading pediatric cancer center, expanding access, accelerating clinical trials and bringing novel therapies to children starting in 2026. Under her leadership, Texas Children’s continues to strengthen its global reputation, integrating translational research into care, scaling access and prioritizing caregiver engagement. Texas Children’s has been ranked No. 1 in Texas and top 10 nationally in all pediatric specialties according to U.S. News & World Report. A Houston native with deep ties to the institution’s legacy, Dr. Sukin is an active industry voice through the American Hospital Association maternal and child health committee, the Texas Hospital Association board and HOSPAC board, and the Angelman Syndrome Foundation’s medical advisory board.
Click here to read the full list.